Terms: = Lymphoma AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12
308 results:
1. Role of plasma EBV-DNA load and EBER status on newly diagnosed peripheral T-cell lymphoma.
Chen J; Zhou J; Cheng F; Chen D; Guan F; Zhang E; He J; Cai Z; Zhao Y
J Cancer Res Clin Oncol; 2024 Apr; 150(4):181. PubMed ID: 38587664
[TBL] [Abstract] [Full Text] [Related]
2. Healthcare Resource Utilization and Cost-of-Illness in Systemic Light Chain (AL) Amyloidosis in Europe: Results From the Real-World, Retrospective EMN23 Study.
Jaccard A; Bridoux F; Roeloffzen W; Minnema MC; Bergantim R; Hájek R; João C; Cibeira MT; Palladini G; Schönland S; Merlini G; Milani P; Dimopoulos MA; Ravichandran S; Hegenbart U; Agis H; Gros B; Asra A; Magarotto V; Cheliotis G; Psarros G; Sonneveld P; Wechalekar A; Kastritis E
Clin Lymphoma Myeloma Leuk; 2024 May; 24(5):e205-e216. PubMed ID: 38453615
[TBL] [Abstract] [Full Text] [Related]
3. Genomic and transcriptomic profiling of peripheral T cell lymphoma reveals distinct molecular and microenvironment subtypes.
Huang YH; Qiu YR; Zhang QL; Cai MC; Yu H; Zhang JM; Jiang L; Ji MM; Xu PP; Wang L; Cheng S; Zhao WL
Cell Rep Med; 2024 Feb; 5(2):101416. PubMed ID: 38350451
[TBL] [Abstract] [Full Text] [Related]
4. HLA-B*58 and HLA-B*27 Play a Role in the Development of Acute Leukemia: A Case Control Study.
Habour Nouar N; Yafour N; Youcef BY; Bouhass R; Chekkal M; Brahimi M; Bekadja MA; Sahraoui T
Asian Pac J Cancer Prev; 2024 Jan; 25(1):169-173. PubMed ID: 38285781
[TBL] [Abstract] [Full Text] [Related]
5. [Mutation characteristics of angioimmunoblastic T-cell lymphoma: an analysis of 75 cases].
Shen X; Yi HM; Li AQ; Ouyang BS; Dong L; Wang CF
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):29-33. PubMed ID: 38178743
[No Abstract] [Full Text] [Related]
6. Clinical and histological study of follicular helper T-cell lymphomas with indolent evolution.
Messéant O; Drieux F; Sako N; Fataccioli V; Camus V; Robe C; Houot R; Tas P; Llamas-Gutierrez F; Lamaison C; Abraham J; Delage-Corre M; Benguerfi S; Bossard JB; Gaulard P; Lemonnier F
Eur J Cancer; 2024 Jan; 197():113479. PubMed ID: 38128263
[TBL] [Abstract] [Full Text] [Related]
7. EBF1, MYO6 and CALR expression levels predict therapeutic response in diffuse large B-cell lymphomas.
Turdo A; Gaggianesi M; D'Accardo C; Porcelli G; Bella SD; Cricchio D; Pillitteri I; Porcasi R; Lo Iacono M; Verona F; Modica C; Roozafzay N; Florena AM; Stassi G; Mancuso S; Todaro M
Front Immunol; 2023; 14():1266265. PubMed ID: 38035116
[TBL] [Abstract] [Full Text] [Related]
8. Angioimmunoblastic T-cell lymphoma and Kaposi sarcoma: A fortuitous collision?
Poullot E; Milowich D; Lemonnier F; Bisig B; Robe C; Pelletier L; Letourneau A; Dupuy A; Sako N; Ketterer N; Carde P; Dartigues P; Delfau-Larue MH; de Leval L; Gaulard P
Histopathology; 2024 Feb; 84(3):556-564. PubMed ID: 37988271
[TBL] [Abstract] [Full Text] [Related]
9. TCR Pathway Mutations in Mature T Cell lymphomas.
Zhang Y; Cheng K; Choi J
J Immunol; 2023 Nov; 211(10):1450-1458. PubMed ID: 37931208
[TBL] [Abstract] [Full Text] [Related]
10. [TFH lymphoma and associated clonal hematopoiesis].
Nann D; Fend F; Quintanilla-Martinez L
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):144-149. PubMed ID: 37870568
[TBL] [Abstract] [Full Text] [Related]
11. Angioimmunoblastic T-cell lymphoma: Novel recurrent mutations and prognostic biomarkers by cell-free DNA profiling.
Zhang C; Mou B; Xu J; Wang J; Liu Q; Yang Y; Tang W; Zhong X; Xu C
Br J Haematol; 2023 Dec; 203(5):807-819. PubMed ID: 37646306
[TBL] [Abstract] [Full Text] [Related]
12. Composite B-cell and T-cell lymphomas: clinical, pathological, and molecular features of three cases and literature review.
Jin X; Liu H; Li J; Xiao X; Yuan X; Chen P; Chen B; Liang Y; Huang F
J Zhejiang Univ Sci B; 2023 Aug; 24(8):711-722. PubMed ID: 37551557
[TBL] [Abstract] [Full Text] [Related]
13. Long-term outcomes in patients with Burkitt lymphoma older than 65 years: an analysis of the Texas Cancer Registry.
Burns EA; Wilson JJ; Mathur S; Kieser R; Gong Z; Hu CA; Tang CA; Petkova J; Yuen C; Mai H; Shah S; Rice L; Ganguly S; Pingali SR
Ann Hematol; 2023 Oct; 102(10):2753-2763. PubMed ID: 37422592
[TBL] [Abstract] [Full Text] [Related]
14. [Analysis of clinicopathological and molecular abnormalities of angioimmunoblastic T-cell lymphoma].
Shi YF; Wang HJ; Liu WP; Mi L; Long MP; Liu YF; Lai YM; Zhou LX; Diao XT; Li XH
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):521-529. PubMed ID: 37291929
[TBL] [Abstract] [Full Text] [Related]
15. Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization.
Clavero E; Sanchez-Maldonado JM; Macauda A; Ter Horst R; Sampaio-Marques B; Jurczyszyn A; Clay-Gilmour A; Stein A; Hildebrandt MAT; Weinhold N; Buda G; García-Sanz R; Tomczak W; Vogel U; Jerez A; Zawirska D; Wątek M; Hofmann JN; Landi S; Spinelli JJ; Butrym A; Kumar A; Martínez-López J; Galimberti S; Sarasquete ME; Subocz E; Iskierka-Jażdżewska E; Giles GG; Rybicka-Ramos M; Kruszewski M; Abildgaard N; Verdejo FG; Sánchez Rovira P; da Silva Filho MI; Kadar K; Razny M; Cozen W; Pelosini M; Jurado M; Bhatti P; Dudzinski M; Druzd-Sitek A; Orciuolo E; Li Y; Norman AD; Zaucha JM; Reis RM; Markiewicz M; Rodríguez Sevilla JJ; Andersen V; Jamroziak K; Hemminki K; Berndt SI; Rajkumar V; Mazur G; Kumar SK; Ludovico P; Nagler A; Chanock SJ; Dumontet C; Machiela MJ; Varkonyi J; Camp NJ; Ziv E; Vangsted AJ; Brown EE; Campa D; Vachon CM; Netea MG; Canzian F; Försti A; Sainz J
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239846
[TBL] [Abstract] [Full Text] [Related]
16. Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach.
Wang S; Deng Z; Wang Y; Bao W; Zhou S; Cui Z; Zheng D
BMC Nephrol; 2023 May; 24(1):146. PubMed ID: 37237260
[TBL] [Abstract] [Full Text] [Related]
17. TIAM1 acts as an actin organization regulator to control adipose tissue-derived pericyte cell fate.
Hsu GC; Wang Y; Lu AZ; Gomez-Salazar MA; Xu J; Li D; Meyers C; Negri S; Wangsiricharoen S; Broderick K; Peault B; Morris C; James AW
JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37219951
[TBL] [Abstract] [Full Text] [Related]
18. Ixazomib Versus Placebo as Postinduction Maintenance Therapy in Newly Diagnosed Multiple Myeloma Patients: An Analysis by Age and Frailty Status of the TOURMALINE-MM4 Study.
Bringhen S; Pour L; Benjamin R; Grosicki S; Min CK; C de Farias DL; Vorog A; Labotka RJ; Wang B; Cherepanov D; Cain LE; Manne S; Rajkumar SV; Dimopoulos MA
Clin Lymphoma Myeloma Leuk; 2023 Jul; 23(7):491-504. PubMed ID: 37149398
[TBL] [Abstract] [Full Text] [Related]
19. Deciphering the spectrum of cutaneous lymphomas expressing TFH markers.
Donzel M; Trecourt A; Balme B; Harou O; Mauduit C; Bachy E; Guesquières H; Fontaine J; Ortonne N; Perier-Muzet M; Dalle S; Traverse-Glehen A
Sci Rep; 2023 Apr; 13(1):6500. PubMed ID: 37081015
[TBL] [Abstract] [Full Text] [Related]
20. A nodal EBV-positive T cell lymphoma with a T follicular helper cell phenotype.
Zhang Z; Wang W; Li Y; Xu Z; Wu H; Wang Z
Histopathology; 2023 Jul; 83(1):137-142. PubMed ID: 37071061
[TBL] [Abstract] [Full Text] [Related]
[Next]